featured
Empagliflozin Treatment Is Associated With Improved Beta-Cell Function in Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Journal of Clinical Endocrinology and Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Empagliflozin Treatment Is Associated With Improved Beta Cell Function in T2DM
J. Clin. Endocrinol. Metab. 2018 Jan 12;[EPub Ahead of Print], H Al Jobori, G Daniele, J Adams, E Cersosimo, C Solis-Herrera, C Triplitt, RA DeFronzo, M Abdul-GhaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.